nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—ADRA1B—Phendimetrazine—obesity	0.195	0.275	CbGbCtD
Midodrine—ADRA1A—Phendimetrazine—obesity	0.154	0.217	CbGbCtD
Midodrine—ADRA1A—Benzphetamine—obesity	0.117	0.164	CbGbCtD
Midodrine—ADRA1A—Phenylpropanolamine—obesity	0.111	0.157	CbGbCtD
Midodrine—CYP2D6—Phentermine—obesity	0.0405	0.057	CbGbCtD
Midodrine—CYP2D6—Bupropion—obesity	0.0344	0.0485	CbGbCtD
Midodrine—CYP2D6—Methamphetamine—obesity	0.0324	0.0456	CbGbCtD
Midodrine—CYP2D6—Cimetidine—obesity	0.0253	0.0356	CbGbCtD
Midodrine—Gastrointestinal disorder—Methamphetamine—obesity	0.00106	0.00639	CcSEcCtD
Midodrine—Tachycardia—Phendimetrazine—obesity	0.00105	0.00635	CcSEcCtD
Midodrine—Nervousness—Phentermine—obesity	0.00105	0.00633	CcSEcCtD
Midodrine—Bradycardia—Cimetidine—obesity	0.00104	0.00631	CcSEcCtD
Midodrine—Dyspepsia—Benzphetamine—obesity	0.00104	0.00628	CcSEcCtD
Midodrine—Cramps of lower extremities—Orlistat—obesity	0.00103	0.00626	CcSEcCtD
Midodrine—Agitation—Phenylpropanolamine—obesity	0.00103	0.00626	CcSEcCtD
Midodrine—Gastrointestinal disorder—Benzphetamine—obesity	0.00102	0.00616	CcSEcCtD
Midodrine—Agomelatine—HTR2C—obesity	0.00102	0.455	CrCbGaD
Midodrine—Hepatic enzyme increased—Bupropion—obesity	0.001	0.00608	CcSEcCtD
Midodrine—Cramps of lower extremities—Sibutramine—obesity	0.001	0.00606	CcSEcCtD
Midodrine—Agitation—Phentermine—obesity	0.00099	0.00599	CcSEcCtD
Midodrine—Insomnia—Phendimetrazine—obesity	0.000973	0.00588	CcSEcCtD
Midodrine—Erythema multiforme—Cimetidine—obesity	0.000969	0.00586	CcSEcCtD
Midodrine—Anxiety—Phenylpropanolamine—obesity	0.000955	0.00578	CcSEcCtD
Midodrine—Sleep disorder—Orlistat—obesity	0.000944	0.00571	CcSEcCtD
Midodrine—Hypertension—Phentermine—obesity	0.00093	0.00563	CcSEcCtD
Midodrine—Confusional state—Phenylpropanolamine—obesity	0.000926	0.0056	CcSEcCtD
Midodrine—Tension—Diethylpropion—obesity	0.00092	0.00556	CcSEcCtD
Midodrine—Sleep disorder—Sibutramine—obesity	0.000914	0.00553	CcSEcCtD
Midodrine—Nervousness—Diethylpropion—obesity	0.00091	0.00551	CcSEcCtD
Midodrine—Hepatic function abnormal—Sibutramine—obesity	0.000905	0.00548	CcSEcCtD
Midodrine—Dry mouth—Phentermine—obesity	0.000897	0.00543	CcSEcCtD
Midodrine—Tachycardia—Phenylpropanolamine—obesity	0.000897	0.00542	CcSEcCtD
Midodrine—Flatulence—Cimetidine—obesity	0.000879	0.00532	CcSEcCtD
Midodrine—Cramps of lower extremities—Bupropion—obesity	0.000873	0.00528	CcSEcCtD
Midodrine—Agitation—Diethylpropion—obesity	0.000861	0.00521	CcSEcCtD
Midodrine—Tachycardia—Phentermine—obesity	0.000858	0.00519	CcSEcCtD
Midodrine—Abdominal pain—Phendimetrazine—obesity	0.00085	0.00514	CcSEcCtD
Midodrine—Insomnia—Phenylpropanolamine—obesity	0.000831	0.00503	CcSEcCtD
Midodrine—Agitation—Cimetidine—obesity	0.000819	0.00496	CcSEcCtD
Midodrine—Dyspnoea—Phenylpropanolamine—obesity	0.000819	0.00495	CcSEcCtD
Midodrine—Somnolence—Phenylpropanolamine—obesity	0.000817	0.00494	CcSEcCtD
Midodrine—Dizziness—Methamphetamine—obesity	0.000809	0.0049	CcSEcCtD
Midodrine—Scotoma—Topiramate—obesity	0.000797	0.00482	CcSEcCtD
Midodrine—Sleep disorder—Bupropion—obesity	0.000797	0.00482	CcSEcCtD
Midodrine—Insomnia—Phentermine—obesity	0.000795	0.00481	CcSEcCtD
Midodrine—Anxiety—Diethylpropion—obesity	0.000795	0.00481	CcSEcCtD
Midodrine—Hepatic function abnormal—Bupropion—obesity	0.000789	0.00477	CcSEcCtD
Midodrine—Dizziness—Benzphetamine—obesity	0.00078	0.00472	CcSEcCtD
Midodrine—Dry mouth—Diethylpropion—obesity	0.00078	0.00472	CcSEcCtD
Midodrine—Dyspepsia—Phentermine—obesity	0.000774	0.00468	CcSEcCtD
Midodrine—Hyperaesthesia—Topiramate—obesity	0.000771	0.00467	CcSEcCtD
Midodrine—Headache—Methamphetamine—obesity	0.000767	0.00464	CcSEcCtD
Midodrine—Gastrointestinal disorder—Phentermine—obesity	0.000759	0.00459	CcSEcCtD
Midodrine—Feeling abnormal—Phenylpropanolamine—obesity	0.000757	0.00458	CcSEcCtD
Midodrine—Anxiety—Cimetidine—obesity	0.000757	0.00458	CcSEcCtD
Midodrine—Urinary retention—Sibutramine—obesity	0.000752	0.00455	CcSEcCtD
Midodrine—Dry skin—Orlistat—obesity	0.000749	0.00453	CcSEcCtD
Midodrine—Tachycardia—Diethylpropion—obesity	0.000746	0.00452	CcSEcCtD
Midodrine—Headache—Benzphetamine—obesity	0.000739	0.00447	CcSEcCtD
Midodrine—Confusional state—Cimetidine—obesity	0.000734	0.00444	CcSEcCtD
Midodrine—Dry skin—Sibutramine—obesity	0.000725	0.00439	CcSEcCtD
Midodrine—Dizziness—Phendimetrazine—obesity	0.000711	0.0043	CcSEcCtD
Midodrine—Tachycardia—Cimetidine—obesity	0.00071	0.0043	CcSEcCtD
Midodrine—Nausea—Benzphetamine—obesity	0.000701	0.00424	CcSEcCtD
Midodrine—Abdominal pain—Phentermine—obesity	0.000695	0.0042	CcSEcCtD
Midodrine—Insomnia—Diethylpropion—obesity	0.000692	0.00418	CcSEcCtD
Midodrine—Vasodilation procedure—Topiramate—obesity	0.000689	0.00417	CcSEcCtD
Midodrine—Vasodilation—Topiramate—obesity	0.000689	0.00417	CcSEcCtD
Midodrine—Dyspnoea—Diethylpropion—obesity	0.000682	0.00412	CcSEcCtD
Midodrine—Somnolence—Diethylpropion—obesity	0.00068	0.00411	CcSEcCtD
Midodrine—Abdominal discomfort—Orlistat—obesity	0.000677	0.0041	CcSEcCtD
Midodrine—Headache—Phendimetrazine—obesity	0.000674	0.00408	CcSEcCtD
Midodrine—Dyspepsia—Diethylpropion—obesity	0.000673	0.00407	CcSEcCtD
Midodrine—Gastrointestinal disorder—Diethylpropion—obesity	0.00066	0.00399	CcSEcCtD
Midodrine—Irritability—Bupropion—obesity	0.000658	0.00398	CcSEcCtD
Midodrine—Urinary retention—Bupropion—obesity	0.000656	0.00397	CcSEcCtD
Midodrine—Drug interaction—Topiramate—obesity	0.000653	0.00395	CcSEcCtD
Midodrine—Somnolence—Cimetidine—obesity	0.000647	0.00391	CcSEcCtD
Midodrine—Hepatic enzyme increased—Topiramate—obesity	0.00064	0.00387	CcSEcCtD
Midodrine—Dysuria—Sibutramine—obesity	0.000639	0.00387	CcSEcCtD
Midodrine—Nausea—Phendimetrazine—obesity	0.000639	0.00386	CcSEcCtD
Midodrine—Melatonin—CYP19A1—obesity	0.000634	0.284	CrCbGaD
Midodrine—Dry skin—Bupropion—obesity	0.000632	0.00382	CcSEcCtD
Midodrine—Pollakiuria—Sibutramine—obesity	0.000632	0.00382	CcSEcCtD
Midodrine—Asthenia—Phentermine—obesity	0.000631	0.00382	CcSEcCtD
Midodrine—Feeling abnormal—Diethylpropion—obesity	0.00063	0.00381	CcSEcCtD
Midodrine—Dizziness—Phenylpropanolamine—obesity	0.000608	0.00368	CcSEcCtD
Midodrine—Feeling abnormal—Cimetidine—obesity	0.0006	0.00363	CcSEcCtD
Midodrine—Hepatobiliary disease—Orlistat—obesity	0.000596	0.0036	CcSEcCtD
Midodrine—Stomatitis—Sibutramine—obesity	0.000594	0.00359	CcSEcCtD
Midodrine—Melatonin—ESR1—obesity	0.000583	0.261	CrCbGaD
Midodrine—Dizziness—Phentermine—obesity	0.000581	0.00352	CcSEcCtD
Midodrine—Rash—Phenylpropanolamine—obesity	0.000579	0.0035	CcSEcCtD
Midodrine—Dermatitis—Phenylpropanolamine—obesity	0.000579	0.0035	CcSEcCtD
Midodrine—Abdominal discomfort—Bupropion—obesity	0.000571	0.00346	CcSEcCtD
Midodrine—Urinary tract disorder—Orlistat—obesity	0.000559	0.00338	CcSEcCtD
Midodrine—Dysuria—Bupropion—obesity	0.000557	0.00337	CcSEcCtD
Midodrine—Bradycardia—Sibutramine—obesity	0.000557	0.00337	CcSEcCtD
Midodrine—Cramps of lower extremities—Topiramate—obesity	0.000556	0.00336	CcSEcCtD
Midodrine—Urethral disorder—Orlistat—obesity	0.000554	0.00335	CcSEcCtD
Midodrine—Rash—Phentermine—obesity	0.000554	0.00335	CcSEcCtD
Midodrine—Dermatitis—Phentermine—obesity	0.000554	0.00335	CcSEcCtD
Midodrine—Headache—Phentermine—obesity	0.000551	0.00333	CcSEcCtD
Midodrine—Pollakiuria—Bupropion—obesity	0.000551	0.00333	CcSEcCtD
Midodrine—Nausea—Phenylpropanolamine—obesity	0.000546	0.0033	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Bupropion—obesity	0.000527	0.00319	CcSEcCtD
Midodrine—Nausea—Phentermine—obesity	0.000522	0.00316	CcSEcCtD
Midodrine—Asthenia—Cimetidine—obesity	0.000522	0.00316	CcSEcCtD
Midodrine—Stomatitis—Bupropion—obesity	0.000518	0.00313	CcSEcCtD
Midodrine—Sleep disorder—Topiramate—obesity	0.000508	0.00307	CcSEcCtD
Midodrine—Dizziness—Diethylpropion—obesity	0.000506	0.00306	CcSEcCtD
Midodrine—Angiopathy—Sibutramine—obesity	0.000497	0.003	CcSEcCtD
Midodrine—Mental disorder—Orlistat—obesity	0.000495	0.003	CcSEcCtD
Midodrine—Chills—Sibutramine—obesity	0.000491	0.00297	CcSEcCtD
Midodrine—Flatulence—Orlistat—obesity	0.000485	0.00293	CcSEcCtD
Midodrine—Rash—Diethylpropion—obesity	0.000482	0.00292	CcSEcCtD
Midodrine—Dermatitis—Diethylpropion—obesity	0.000482	0.00291	CcSEcCtD
Midodrine—Dizziness—Cimetidine—obesity	0.000481	0.00291	CcSEcCtD
Midodrine—Headache—Diethylpropion—obesity	0.000479	0.0029	CcSEcCtD
Midodrine—Back pain—Orlistat—obesity	0.000476	0.00288	CcSEcCtD
Midodrine—Muscle spasms—Orlistat—obesity	0.000473	0.00286	CcSEcCtD
Midodrine—Urinary tract disorder—Bupropion—obesity	0.000471	0.00285	CcSEcCtD
Midodrine—Flatulence—Sibutramine—obesity	0.000469	0.00284	CcSEcCtD
Midodrine—Urethral disorder—Bupropion—obesity	0.000468	0.00283	CcSEcCtD
Midodrine—Tension—Sibutramine—obesity	0.000468	0.00283	CcSEcCtD
Midodrine—Nervousness—Sibutramine—obesity	0.000463	0.0028	CcSEcCtD
Midodrine—Back pain—Sibutramine—obesity	0.000461	0.00279	CcSEcCtD
Midodrine—Rash—Cimetidine—obesity	0.000459	0.00278	CcSEcCtD
Midodrine—Dermatitis—Cimetidine—obesity	0.000458	0.00277	CcSEcCtD
Midodrine—Muscle spasms—Sibutramine—obesity	0.000458	0.00277	CcSEcCtD
Midodrine—Headache—Cimetidine—obesity	0.000456	0.00276	CcSEcCtD
Midodrine—Nausea—Diethylpropion—obesity	0.000454	0.00275	CcSEcCtD
Midodrine—Erythema multiforme—Bupropion—obesity	0.000451	0.00273	CcSEcCtD
Midodrine—Cardiac disorder—Bupropion—obesity	0.000443	0.00268	CcSEcCtD
Midodrine—Flushing—Bupropion—obesity	0.000443	0.00268	CcSEcCtD
Midodrine—Agitation—Sibutramine—obesity	0.000438	0.00265	CcSEcCtD
Midodrine—Angiopathy—Bupropion—obesity	0.000433	0.00262	CcSEcCtD
Midodrine—Nausea—Cimetidine—obesity	0.000432	0.00261	CcSEcCtD
Midodrine—Chills—Bupropion—obesity	0.000428	0.00259	CcSEcCtD
Midodrine—Irritability—Topiramate—obesity	0.000419	0.00254	CcSEcCtD
Midodrine—Mental disorder—Bupropion—obesity	0.000418	0.00253	CcSEcCtD
Midodrine—Urinary retention—Topiramate—obesity	0.000418	0.00253	CcSEcCtD
Midodrine—Anxiety—Orlistat—obesity	0.000418	0.00253	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000416	0.00252	CcSEcCtD
Midodrine—Hypertension—Sibutramine—obesity	0.000411	0.00249	CcSEcCtD
Midodrine—Dry mouth—Orlistat—obesity	0.00041	0.00248	CcSEcCtD
Midodrine—Flatulence—Bupropion—obesity	0.000409	0.00248	CcSEcCtD
Midodrine—Tension—Bupropion—obesity	0.000408	0.00247	CcSEcCtD
Midodrine—Anxiety—Sibutramine—obesity	0.000404	0.00245	CcSEcCtD
Midodrine—Nervousness—Bupropion—obesity	0.000403	0.00244	CcSEcCtD
Midodrine—Back pain—Bupropion—obesity	0.000402	0.00243	CcSEcCtD
Midodrine—Muscle spasms—Bupropion—obesity	0.000399	0.00242	CcSEcCtD
Midodrine—Dry mouth—Sibutramine—obesity	0.000397	0.0024	CcSEcCtD
Midodrine—Nervous system disorder—Orlistat—obesity	0.000394	0.00238	CcSEcCtD
Midodrine—Confusional state—Sibutramine—obesity	0.000392	0.00237	CcSEcCtD
Midodrine—Skin disorder—Orlistat—obesity	0.00039	0.00236	CcSEcCtD
Midodrine—Agitation—Bupropion—obesity	0.000382	0.00231	CcSEcCtD
Midodrine—Tachycardia—Sibutramine—obesity	0.00038	0.0023	CcSEcCtD
Midodrine—Skin disorder—Sibutramine—obesity	0.000378	0.00228	CcSEcCtD
Midodrine—Abdominal discomfort—Topiramate—obesity	0.000364	0.0022	CcSEcCtD
Midodrine—Insomnia—Orlistat—obesity	0.000363	0.0022	CcSEcCtD
Midodrine—Paraesthesia—Orlistat—obesity	0.000361	0.00218	CcSEcCtD
Midodrine—Hypertension—Bupropion—obesity	0.000359	0.00217	CcSEcCtD
Midodrine—Dysuria—Topiramate—obesity	0.000355	0.00215	CcSEcCtD
Midodrine—Dyspepsia—Orlistat—obesity	0.000354	0.00214	CcSEcCtD
Midodrine—Anxiety—Bupropion—obesity	0.000352	0.00213	CcSEcCtD
Midodrine—Insomnia—Sibutramine—obesity	0.000352	0.00213	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000351	0.00212	CcSEcCtD
Midodrine—Pollakiuria—Topiramate—obesity	0.000351	0.00212	CcSEcCtD
Midodrine—Paraesthesia—Sibutramine—obesity	0.000349	0.00211	CcSEcCtD
Midodrine—Gastrointestinal disorder—Orlistat—obesity	0.000347	0.0021	CcSEcCtD
Midodrine—Dyspnoea—Sibutramine—obesity	0.000347	0.0021	CcSEcCtD
Midodrine—Dry mouth—Bupropion—obesity	0.000346	0.00209	CcSEcCtD
Midodrine—Somnolence—Sibutramine—obesity	0.000346	0.00209	CcSEcCtD
Midodrine—Pain—Orlistat—obesity	0.000344	0.00208	CcSEcCtD
Midodrine—Dyspepsia—Sibutramine—obesity	0.000342	0.00207	CcSEcCtD
Midodrine—Confusional state—Bupropion—obesity	0.000342	0.00207	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Topiramate—obesity	0.000336	0.00203	CcSEcCtD
Midodrine—Gastrointestinal disorder—Sibutramine—obesity	0.000336	0.00203	CcSEcCtD
Midodrine—Pain—Sibutramine—obesity	0.000333	0.00201	CcSEcCtD
Midodrine—Nervous system disorder—Bupropion—obesity	0.000332	0.00201	CcSEcCtD
Midodrine—Feeling abnormal—Orlistat—obesity	0.000331	0.002	CcSEcCtD
Midodrine—Tachycardia—Bupropion—obesity	0.000331	0.002	CcSEcCtD
Midodrine—Stomatitis—Topiramate—obesity	0.00033	0.002	CcSEcCtD
Midodrine—Skin disorder—Bupropion—obesity	0.000329	0.00199	CcSEcCtD
Midodrine—Gastrointestinal pain—Orlistat—obesity	0.000329	0.00199	CcSEcCtD
Midodrine—Feeling abnormal—Sibutramine—obesity	0.00032	0.00194	CcSEcCtD
Midodrine—Gastrointestinal pain—Sibutramine—obesity	0.000318	0.00192	CcSEcCtD
Midodrine—Abdominal pain—Orlistat—obesity	0.000318	0.00192	CcSEcCtD
Midodrine—Bradycardia—Topiramate—obesity	0.000309	0.00187	CcSEcCtD
Midodrine—Abdominal pain—Sibutramine—obesity	0.000307	0.00186	CcSEcCtD
Midodrine—Insomnia—Bupropion—obesity	0.000307	0.00185	CcSEcCtD
Midodrine—Paraesthesia—Bupropion—obesity	0.000304	0.00184	CcSEcCtD
Midodrine—Dyspnoea—Bupropion—obesity	0.000302	0.00183	CcSEcCtD
Midodrine—Somnolence—Bupropion—obesity	0.000301	0.00182	CcSEcCtD
Midodrine—Urinary tract disorder—Topiramate—obesity	0.0003	0.00182	CcSEcCtD
Midodrine—Dyspepsia—Bupropion—obesity	0.000298	0.00181	CcSEcCtD
Midodrine—Urethral disorder—Topiramate—obesity	0.000298	0.0018	CcSEcCtD
Midodrine—Gastrointestinal disorder—Bupropion—obesity	0.000293	0.00177	CcSEcCtD
Midodrine—Pain—Bupropion—obesity	0.00029	0.00175	CcSEcCtD
Midodrine—Asthenia—Orlistat—obesity	0.000288	0.00174	CcSEcCtD
Midodrine—Erythema multiforme—Topiramate—obesity	0.000287	0.00174	CcSEcCtD
Midodrine—Pruritus—Orlistat—obesity	0.000284	0.00172	CcSEcCtD
Midodrine—Cardiac disorder—Topiramate—obesity	0.000282	0.00171	CcSEcCtD
Midodrine—Flushing—Topiramate—obesity	0.000282	0.00171	CcSEcCtD
Midodrine—Feeling abnormal—Bupropion—obesity	0.000279	0.00169	CcSEcCtD
Midodrine—Asthenia—Sibutramine—obesity	0.000279	0.00169	CcSEcCtD
Midodrine—Gastrointestinal pain—Bupropion—obesity	0.000277	0.00168	CcSEcCtD
Midodrine—Angiopathy—Topiramate—obesity	0.000276	0.00167	CcSEcCtD
Midodrine—Pruritus—Sibutramine—obesity	0.000275	0.00166	CcSEcCtD
Midodrine—Chills—Topiramate—obesity	0.000273	0.00165	CcSEcCtD
Midodrine—Abdominal pain—Bupropion—obesity	0.000268	0.00162	CcSEcCtD
Midodrine—Mental disorder—Topiramate—obesity	0.000266	0.00161	CcSEcCtD
Midodrine—Dizziness—Orlistat—obesity	0.000266	0.00161	CcSEcCtD
Midodrine—Flatulence—Topiramate—obesity	0.000261	0.00158	CcSEcCtD
Midodrine—Tension—Topiramate—obesity	0.00026	0.00157	CcSEcCtD
Midodrine—Dizziness—Sibutramine—obesity	0.000257	0.00156	CcSEcCtD
Midodrine—Nervousness—Topiramate—obesity	0.000257	0.00155	CcSEcCtD
Midodrine—Back pain—Topiramate—obesity	0.000256	0.00155	CcSEcCtD
Midodrine—Muscle spasms—Topiramate—obesity	0.000254	0.00154	CcSEcCtD
Midodrine—Rash—Orlistat—obesity	0.000253	0.00153	CcSEcCtD
Midodrine—Dermatitis—Orlistat—obesity	0.000253	0.00153	CcSEcCtD
Midodrine—Headache—Orlistat—obesity	0.000252	0.00152	CcSEcCtD
Midodrine—Rash—Sibutramine—obesity	0.000245	0.00148	CcSEcCtD
Midodrine—Dermatitis—Sibutramine—obesity	0.000245	0.00148	CcSEcCtD
Midodrine—Headache—Sibutramine—obesity	0.000244	0.00147	CcSEcCtD
Midodrine—Asthenia—Bupropion—obesity	0.000243	0.00147	CcSEcCtD
Midodrine—Agitation—Topiramate—obesity	0.000243	0.00147	CcSEcCtD
Midodrine—Pruritus—Bupropion—obesity	0.00024	0.00145	CcSEcCtD
Midodrine—Nausea—Orlistat—obesity	0.000239	0.00144	CcSEcCtD
Midodrine—Nausea—Sibutramine—obesity	0.000231	0.0014	CcSEcCtD
Midodrine—Hypertension—Topiramate—obesity	0.000228	0.00138	CcSEcCtD
Midodrine—Anxiety—Topiramate—obesity	0.000225	0.00136	CcSEcCtD
Midodrine—Dizziness—Bupropion—obesity	0.000224	0.00136	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000224	0.00135	CcSEcCtD
Midodrine—Dry mouth—Topiramate—obesity	0.00022	0.00133	CcSEcCtD
Midodrine—Confusional state—Topiramate—obesity	0.000218	0.00132	CcSEcCtD
Midodrine—Rash—Bupropion—obesity	0.000214	0.00129	CcSEcCtD
Midodrine—Dermatitis—Bupropion—obesity	0.000214	0.00129	CcSEcCtD
Midodrine—Headache—Bupropion—obesity	0.000212	0.00128	CcSEcCtD
Midodrine—Nervous system disorder—Topiramate—obesity	0.000212	0.00128	CcSEcCtD
Midodrine—Tachycardia—Topiramate—obesity	0.000211	0.00128	CcSEcCtD
Midodrine—Skin disorder—Topiramate—obesity	0.00021	0.00127	CcSEcCtD
Midodrine—Nausea—Bupropion—obesity	0.000201	0.00122	CcSEcCtD
Midodrine—Insomnia—Topiramate—obesity	0.000195	0.00118	CcSEcCtD
Midodrine—Paraesthesia—Topiramate—obesity	0.000194	0.00117	CcSEcCtD
Midodrine—Dyspnoea—Topiramate—obesity	0.000193	0.00116	CcSEcCtD
Midodrine—Somnolence—Topiramate—obesity	0.000192	0.00116	CcSEcCtD
Midodrine—Dyspepsia—Topiramate—obesity	0.00019	0.00115	CcSEcCtD
Midodrine—Gastrointestinal disorder—Topiramate—obesity	0.000186	0.00113	CcSEcCtD
Midodrine—Pain—Topiramate—obesity	0.000185	0.00112	CcSEcCtD
Midodrine—Feeling abnormal—Topiramate—obesity	0.000178	0.00108	CcSEcCtD
Midodrine—Gastrointestinal pain—Topiramate—obesity	0.000177	0.00107	CcSEcCtD
Midodrine—Abdominal pain—Topiramate—obesity	0.000171	0.00103	CcSEcCtD
Midodrine—Asthenia—Topiramate—obesity	0.000155	0.000937	CcSEcCtD
Midodrine—Pruritus—Topiramate—obesity	0.000153	0.000924	CcSEcCtD
Midodrine—Dizziness—Topiramate—obesity	0.000143	0.000864	CcSEcCtD
Midodrine—Rash—Topiramate—obesity	0.000136	0.000824	CcSEcCtD
Midodrine—Dermatitis—Topiramate—obesity	0.000136	0.000823	CcSEcCtD
Midodrine—Headache—Topiramate—obesity	0.000135	0.000818	CcSEcCtD
Midodrine—Nausea—Topiramate—obesity	0.000128	0.000776	CcSEcCtD
Midodrine—ADRA1A—Signaling Pathways—PARP1—obesity	1.16e-05	9.45e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCL5—obesity	1.16e-05	9.41e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—DRD4—obesity	1.15e-05	9.37e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—POMC—obesity	1.14e-05	9.31e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PRL—obesity	1.14e-05	9.28e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CLOCK—obesity	1.14e-05	9.27e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SLC22A1—obesity	1.14e-05	9.27e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—LPL—obesity	1.13e-05	9.2e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—STK11—obesity	1.12e-05	9.15e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—FOXO1—obesity	1.12e-05	9.13e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RPS6KB1—obesity	1.12e-05	9.12e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCL2—obesity	1.12e-05	9.11e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—POMC—obesity	1.12e-05	9.11e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PRKCB—obesity	1.12e-05	9.08e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—F2—obesity	1.12e-05	9.08e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PLG—obesity	1.11e-05	9.05e-05	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—RHOA—obesity	1.11e-05	9.03e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SULT2A1—obesity	1.11e-05	9.03e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GLP1R—obesity	1.11e-05	9.03e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—PIK3CB—obesity	1.11e-05	9.03e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CNR1—obesity	1.1e-05	8.95e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—AKT2—obesity	1.1e-05	8.95e-05	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PIK3R1—obesity	1.1e-05	8.94e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—DPYD—obesity	1.09e-05	8.88e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FOXO3—obesity	1.09e-05	8.83e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADRB2—obesity	1.08e-05	8.81e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TCF7L2—obesity	1.08e-05	8.79e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—AKT2—obesity	1.08e-05	8.75e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—DRD2—obesity	1.07e-05	8.73e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PIK3CG—obesity	1.07e-05	8.69e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SOCS1—obesity	1.07e-05	8.67e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GCG—obesity	1.06e-05	8.64e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PTPN1—obesity	1.06e-05	8.64e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PIK3CD—obesity	1.06e-05	8.6e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SOCS3—obesity	1.05e-05	8.57e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PRKAR2B—obesity	1.05e-05	8.55e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—DCN—obesity	1.04e-05	8.49e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PRKCD—obesity	1.04e-05	8.48e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PIK3CD—obesity	1.03e-05	8.41e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GNB3—obesity	1.03e-05	8.39e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HTR2A—obesity	1.02e-05	8.3e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—C3—obesity	1.02e-05	8.28e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—TYK2—obesity	1.02e-05	8.27e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—POMC—obesity	1.02e-05	8.27e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CPT1A—obesity	1.02e-05	8.26e-05	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PIK3CB—obesity	1.01e-05	8.25e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRL—obesity	1.01e-05	8.25e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IGF2—obesity	1.01e-05	8.24e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—RHOA—obesity	1.01e-05	8.2e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GNAS—obesity	1e-05	8.17e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—STK11—obesity	9.99e-06	8.13e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PIK3R1—obesity	9.98e-06	8.12e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NAMPT—obesity	9.96e-06	8.1e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCL2—obesity	9.95e-06	8.09e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—LIPC—obesity	9.89e-06	8.05e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GCK—obesity	9.89e-06	8.05e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PLG—obesity	9.88e-06	8.04e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—RHOA—obesity	9.86e-06	8.02e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOC3—obesity	9.83e-06	8e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOB—obesity	9.83e-06	8e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AKT2—obesity	9.77e-06	7.95e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PIK3R1—obesity	9.76e-06	7.94e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IRS2—obesity	9.69e-06	7.88e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AGT—obesity	9.68e-06	7.87e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FOXO3—obesity	9.64e-06	7.84e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADRB2—obesity	9.62e-06	7.82e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCL5—obesity	9.6e-06	7.81e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CETP—obesity	9.55e-06	7.77e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—LEP—obesity	9.48e-06	7.71e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APOE—obesity	9.48e-06	7.71e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SOCS1—obesity	9.47e-06	7.7e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SDC1—obesity	9.44e-06	7.68e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CAV1—obesity	9.39e-06	7.64e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—LPL—obesity	9.39e-06	7.64e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PIK3CD—obesity	9.39e-06	7.64e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APOA1—obesity	9.37e-06	7.62e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SOCS3—obesity	9.36e-06	7.61e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FOXO1—obesity	9.32e-06	7.58e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RPS6KB1—obesity	9.3e-06	7.57e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AKR1C3—obesity	9.29e-06	7.55e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PIK3CB—obesity	9.21e-06	7.49e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GNB3—obesity	9.16e-06	7.45e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SCARB1—obesity	9.14e-06	7.44e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ESR1—obesity	9.05e-06	7.36e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—TYK2—obesity	9.03e-06	7.35e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PIK3CB—obesity	9.01e-06	7.33e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IGF2—obesity	9e-06	7.32e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—RHOA—obesity	8.96e-06	7.29e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—F2—obesity	8.94e-06	7.27e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PRKCB—obesity	8.94e-06	7.27e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GNAS—obesity	8.92e-06	7.25e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SREBF1—obesity	8.88e-06	7.22e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PIK3R1—obesity	8.87e-06	7.21e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—BAD—obesity	8.84e-06	7.19e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOB—obesity	8.73e-06	7.1e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PRKCD—obesity	8.65e-06	7.04e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GOT2—obesity	8.63e-06	7.02e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PIK3CG—obesity	8.56e-06	6.96e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCL5—obesity	8.53e-06	6.94e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HTR2A—obesity	8.47e-06	6.89e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IRS1—obesity	8.46e-06	6.88e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—C3—obesity	8.45e-06	6.88e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—FASN—obesity	8.45e-06	6.87e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—BCHE—obesity	8.41e-06	6.84e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—LPL—obesity	8.34e-06	6.78e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FOXO1—obesity	8.28e-06	6.73e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RPS6KB1—obesity	8.26e-06	6.72e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PIK3CB—obesity	8.18e-06	6.66e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—POMC—obesity	8.15e-06	6.63e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP2E1—obesity	8.12e-06	6.6e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—INS—obesity	8.1e-06	6.59e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IRS2—obesity	8.04e-06	6.54e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AGT—obesity	8.03e-06	6.53e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NQO1—obesity	8.03e-06	6.53e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCL2—obesity	7.97e-06	6.48e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—LEP—obesity	7.87e-06	6.4e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOE—obesity	7.87e-06	6.4e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IGF1—obesity	7.84e-06	6.37e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AKT2—obesity	7.83e-06	6.37e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CAV1—obesity	7.8e-06	6.34e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOA1—obesity	7.78e-06	6.33e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GCG—obesity	7.7e-06	6.26e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SLC2A4—obesity	7.7e-06	6.26e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRKCD—obesity	7.68e-06	6.25e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYCS—obesity	7.59e-06	6.18e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PIK3CD—obesity	7.52e-06	6.12e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HTR2A—obesity	7.52e-06	6.12e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ESR1—obesity	7.51e-06	6.11e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—C3—obesity	7.51e-06	6.11e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GGT1—obesity	7.45e-06	6.06e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GOT1—obesity	7.45e-06	6.06e-05	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—PIK3CA—obesity	7.45e-06	6.06e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SERPINE1—obesity	7.44e-06	6.05e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—F2—obesity	7.42e-06	6.04e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PRKCB—obesity	7.42e-06	6.04e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NCOA1—obesity	7.34e-06	5.97e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—BAD—obesity	7.33e-06	5.96e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TYK2—obesity	7.24e-06	5.89e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP19A1—obesity	7.23e-06	5.88e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—STK11—obesity	7.23e-06	5.88e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RHOA—obesity	7.18e-06	5.84e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IRS2—obesity	7.14e-06	5.81e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AGT—obesity	7.13e-06	5.8e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NOS3—obesity	7.1e-06	5.78e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PIK3R1—obesity	7.1e-06	5.78e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PIK3CG—obesity	7.1e-06	5.78e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IRS1—obesity	7.02e-06	5.71e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOE—obesity	6.99e-06	5.69e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—LEP—obesity	6.99e-06	5.69e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CAV1—obesity	6.93e-06	5.63e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOA1—obesity	6.91e-06	5.62e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—PIK3CA—obesity	6.77e-06	5.5e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—POMC—obesity	6.76e-06	5.5e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—COMT—obesity	6.73e-06	5.47e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—INS—obesity	6.72e-06	5.47e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ESR1—obesity	6.67e-06	5.43e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GNB3—obesity	6.63e-06	5.39e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARGC1A—obesity	6.63e-06	5.39e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCL2—obesity	6.61e-06	5.38e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HMOX1—obesity	6.6e-06	5.37e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRKCB—obesity	6.59e-06	5.36e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—F2—obesity	6.59e-06	5.36e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PIK3CB—obesity	6.56e-06	5.33e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MTOR—obesity	6.56e-06	5.33e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—BAD—obesity	6.51e-06	5.3e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IGF1—obesity	6.5e-06	5.29e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AKT2—obesity	6.5e-06	5.29e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GNAS—obesity	6.46e-06	5.25e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOB—obesity	6.32e-06	5.14e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PIK3CG—obesity	6.31e-06	5.13e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PIK3CD—obesity	6.24e-06	5.08e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IRS1—obesity	6.24e-06	5.07e-05	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PIK3CA—obesity	6.18e-06	5.03e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SERPINE1—obesity	6.18e-06	5.02e-05	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—AKT1—obesity	6.09e-06	4.95e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—LPL—obesity	6.04e-06	4.91e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TYK2—obesity	6.01e-06	4.89e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—POMC—obesity	6.01e-06	4.88e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL6—obesity	5.99e-06	4.87e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—INS—obesity	5.97e-06	4.86e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RHOA—obesity	5.96e-06	4.85e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PIK3R1—obesity	5.9e-06	4.8e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NOS3—obesity	5.9e-06	4.8e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GPX1—obesity	5.89e-06	4.79e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCL2—obesity	5.88e-06	4.78e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IGF1—obesity	5.78e-06	4.7e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AKT2—obesity	5.77e-06	4.69e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CD36—obesity	5.74e-06	4.67e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MMP9—obesity	5.7e-06	4.64e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PIK3CA—obesity	5.62e-06	4.57e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PIK3CD—obesity	5.55e-06	4.51e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MAPK8—obesity	5.54e-06	4.51e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—AKT1—obesity	5.53e-06	4.5e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	5.49e-06	4.47e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SERPINE1—obesity	5.49e-06	4.46e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MTOR—obesity	5.44e-06	4.43e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PIK3CB—obesity	5.44e-06	4.43e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—MTHFR—obesity	5.44e-06	4.42e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TYK2—obesity	5.34e-06	4.34e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARA—obesity	5.33e-06	4.34e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RHOA—obesity	5.29e-06	4.3e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NOS3—obesity	5.24e-06	4.26e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PIK3R1—obesity	5.24e-06	4.26e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AGT—obesity	5.17e-06	4.2e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—STAT3—obesity	5.07e-06	4.12e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOE—obesity	5.06e-06	4.12e-05	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—AKT1—obesity	5.05e-06	4.11e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CAV1—obesity	5.01e-06	4.08e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOA1—obesity	5e-06	4.07e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PIK3CA—obesity	4.99e-06	4.06e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6—obesity	4.97e-06	4.04e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PIK3CB—obesity	4.83e-06	3.93e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MTOR—obesity	4.83e-06	3.93e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MMP9—obesity	4.73e-06	3.85e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MYC—obesity	4.71e-06	3.83e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TGFB1—obesity	4.7e-06	3.82e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MAPK8—obesity	4.6e-06	3.74e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—AKT1—obesity	4.59e-06	3.73e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PIK3CG—obesity	4.57e-06	3.72e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—AKT1—obesity	4.49e-06	3.65e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6—obesity	4.42e-06	3.59e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARG—obesity	4.41e-06	3.59e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—POMC—obesity	4.35e-06	3.54e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—INS—obesity	4.32e-06	3.52e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—STAT3—obesity	4.21e-06	3.42e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MMP9—obesity	4.2e-06	3.42e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MAPK8—obesity	4.09e-06	3.32e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AKT1—obesity	4.08e-06	3.31e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PIK3CD—obesity	4.02e-06	3.27e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PIK3CA—obesity	4e-06	3.25e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALB—obesity	3.96e-06	3.22e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MYC—obesity	3.91e-06	3.18e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TGFB1—obesity	3.9e-06	3.17e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PIK3R1—obesity	3.79e-06	3.08e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NOS3—obesity	3.79e-06	3.08e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—STAT3—obesity	3.74e-06	3.04e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6—obesity	3.54e-06	2.88e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PIK3CB—obesity	3.5e-06	2.85e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MYC—obesity	3.47e-06	2.82e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PTGS2—obesity	3.47e-06	2.82e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TGFB1—obesity	3.46e-06	2.82e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PIK3CA—obesity	3.32e-06	2.7e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AKT1—obesity	3.27e-06	2.66e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PIK3CA—obesity	2.95e-06	2.4e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6—obesity	2.94e-06	2.39e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AKT1—obesity	2.71e-06	2.2e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6—obesity	2.61e-06	2.12e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AKT1—obesity	2.41e-06	1.96e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PIK3CA—obesity	2.13e-06	1.74e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AKT1—obesity	1.74e-06	1.42e-05	CbGpPWpGaD
